Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2014 May 21;9(4):522–532. doi: 10.1007/s11481-014-9547-z

Fig. 3.

Fig. 3

Lymphoproliferation suppression assays were set up and ND (n=3) or HAM/TSP (n=2) CD4+CD25+ T cells were added at different ratios of Treg:Teff = 0.25:1 (A), 0.5:1 (B) and 1:1 (C). The % suppressions of Treg were normalized to Teff proliferation without Treg. (D) Correlation between CD4+CD25+ TSDR % demethylation and suppressive capacity as determined in lymphoproliferation suppression assays at Treg:Teff ratio of 1:1.